Home / Auditor changes / Greenwich LifeSciences, Inc.
Filed 2025-07-24 路 Form 8-K 路 Accession 0001641172-25-020843 micro
Price before filing: $11.49 (2025-07-23 close, split/dividend-adjusted)
Market cap at flag: $156.7M (2025-07-24) 路 Latest: $212.7M (2026-10-16)
| Window | GLSI | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +3.5% | +1.3% | +2.2% | 2025-08-25 |
| 90 days | -21.1% | +5.6% | -26.7% | 2025-10-22 |
| 180 days | +85.3% | +7.5% | +77.8% | 2026-01-20 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"(the "Company") approved the dismissal of RBSM LLP ("RBSM") as the Company's independent registered public accounting firm and approved the engagement of MaloneBailey LLP ("MaloneBailey") as the Company's independent registered public accounting firm to audit the Company's consolidated financial statements for the year ended December 31, 2025."
Quoted from the filing. Source
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: dismissed
Disagreements reported: no
Why this score: also within 90 days: Going-concern doubt
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Newsletter delivered by beehiiv. See our privacy policy.